Dr. Britt H. Bolemon, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
65 International Dr
Greenville, SC 29615
Who else practices at this address →
Greenville County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Mercer University School of Medicine (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 990
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Medical school: Mercer University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
SC license 29169 · NC license 2009-00650 -
Hematology (Internal Medicine) Physician
SC license 29169 -
Internal Medicine Physician
SC license 29169 -
Medical Oncology Physician
SC license 29169
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Prisma Health Greenville Memorial Hospital Greenville, SC
- Prisma Health PAtewood Hospital Greenville, SC
- Prisma Health Greer Memorial Hospital Spartanburg, SC
- Prisma Health Hillcrest Hospital Simpsonville, SC
- Prisma Health Oconee Memorial Hospital Seneca, SC
Medical groups
- Prisma Health University Medical Group (2,493 clinicians)
- Anderson Oncology-Hematology Clinic PA (5 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 990
- Services billed
- 6,291
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 2,147 | 461 |
| Established patient office or other outpatient visit, 30-39 minutes | 707 | 296 |
| Established patient office or other outpatient visit, 20-29 minutes | 275 | 132 |
| Established patient office or other outpatient visit, 40-54 minutes | 157 | 119 |
| New patient office or other outpatient visit, 60-74 minutes | 50 | 50 |
| New patient office or other outpatient visit, 45-59 minutes | 20 | 20 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisone Other prescribers in Greenville, SC | 350 |
| Abiraterone Acetate | 241 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Greenville, SC | 110 |
| Ondansetron Hcl Other prescribers in Greenville, SC | 104 |
| Oxycodone Hcl Other prescribers in Greenville, SC | 99 |
| Gabapentin Other prescribers in Greenville, SC | 95 |
| Levofloxacin Other prescribers in Greenville, SC | 74 |
| Dexamethasone Other prescribers in Greenville, SC | 74 |
| Promethazine Hcl Other prescribers in Greenville, SC | 72 |
| Tramadol Hcl Other prescribers in Greenville, SC | 60 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 27 companies reported 40 payments worth $1,217 in total to this clinician.
| Beone Medicines USA, Inc. | $168 |
|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $146 |
| Genmab U.S., Inc. | $122 |
| Apellis Pharmaceuticals, Inc. | $75.56 |
| Astellas Pharma US Inc | $75.19 |
| Merck Sharp & Dohme LLC | $52.31 |
| GlaxoSmithKline, LLC. | $50.20 |
| AstraZeneca Pharmaceuticals LP | $43.26 |
| Food and Beverage | $1,123 |
|---|---|
| Education | $94.49 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Apellis Pharmaceuticals, Inc. Aug 13, 2025 | Education Empaveli · Hematology · in-kind | $45.27 |
| Apellis Pharmaceuticals, Inc. May 27, 2025 | Education Empaveli · Hematology · in-kind | $30.29 |
| E.r. Squibb & Sons, L.l.c. Feb 21, 2025 | Education SPRYCEL · Oncology · in-kind | $18.93 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $65,494 in research payments for these studies, mostly to the institutions running them.
- A Phase III Double-Blind Randomised Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Docetaxel Versus Placebo + Docetaxel as Treatment for Patients with Metastatic Castration Resistant Pros…
AstraZeneca UK Limited - Tiragolumab Tecentriq vs Durvalumab in Unresectable Stage III NSCLC
Genentech, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.